2017
Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS)
Leon J, Hommer R, Grant P, Farmer C, D’Souza P, Kessler R, Williams K, Leckman JF, Swedo S. Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS). European Child & Adolescent Psychiatry 2017, 27: 637-643. PMID: 29119300, DOI: 10.1007/s00787-017-1077-9.Peer-Reviewed Original ResearchConceptsPediatric autoimmune neuropsychiatric disordersAutoimmune neuropsychiatric disordersIntravenous immunoglobulinStreptococcal infectionDose of IVIGNeuropsychiatric disordersPlacebo-controlled trialSignificant obsessive-compulsive symptomsPopulation of childrenCognitive behavioral therapySubacute illnessSydenham's choreaBlinded infusionChronic coursePsychiatric medicationsTreatment modalitiesSpecific symptomsChildhood-onset OCDLongitudinal courseNatural historyObsessive-compulsive symptomsBehavioral therapyExacerbationParents of participantsTelephone interviews
2003
Tourette’s syndrome in children
Swain JE, Leckman JF. Tourette’s syndrome in children. Current Treatment Options In Neurology 2003, 5: 299-308. PMID: 12791197, DOI: 10.1007/s11940-003-0036-6.Peer-Reviewed Original ResearchTourette syndromeSide effectsComorbid conditionsPharmacologic agentsCourse of ticsLow-dose neurolepticsRealistic treatment expectationsAvailable pharmacologic agentsAttention deficit hyperactivity disorderBenefits of interventionsCommitted cliniciansDeficit hyperactivity disorderObsessive-compulsive disorderTreatment optionsSuccessful treatmentClinical trialsSomatic treatmentsTreatment responseSpecific symptomsEffective treatmentCommon treatmentTreatment expectationsTic severityTic controlNeurophysiologic basis